Literature DB >> 10746205

Borderline personality and obsessive-compulsive symptoms.

D McKay1, S Kulchycky, S Danyko.   

Abstract

Diagnostic criteria for borderline personality disorder (BPD) are diverse, covering a broad range of symptoms. One criterion, self-mutilation, is a behavioral excess that may be considered a predictor of other psychopathological states. The present study sought to determine the extent to which two groups of BPD patients, those who mutilate and those who do not, differed on measures of general psychopathology, depression, anxiety, and obsessive-compulsive symptoms. Results indicate that the only source of significant variation was the level of obsessive-compulsive symptoms, with mutilators exhibiting greater symptomatology. The findings from this study support the idea that self-mutilation is a more severe form of psychopathology relative to the rest of the BPD population. These results are interpreted based on the affect regulation model of self-mutilation, and contrasted with contemporary models of impulse control in relation to obsessive-compulsive disorder.

Entities:  

Mesh:

Year:  2000        PMID: 10746205     DOI: 10.1521/pedi.2000.14.1.57

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  4 in total

Review 1.  Should nonsuicidal self-injury be a putative obsessive-compulsive-related condition? A critical appraisal.

Authors:  Dean McKay; Margaret Andover
Journal:  Behav Modif       Date:  2011-09-01

2.  The association of personality disorders with the prospective 7-year course of anxiety disorders.

Authors:  E B Ansell; A Pinto; M O Edelen; J C Markowitz; C A Sanislow; S Yen; M Zanarini; A E Skodol; M T Shea; L C Morey; J G Gunderson; T H McGlashan; C M Grilo
Journal:  Psychol Med       Date:  2010-09-14       Impact factor: 7.723

3.  The Transdiagnostic Relevance of Self-Other Distinction to Psychiatry Spans Emotional, Cognitive and Motor Domains.

Authors:  Clare M Eddy
Journal:  Front Psychiatry       Date:  2022-03-10       Impact factor: 4.157

4.  Treatment of borderline personality disorder and co-occurring anxiety disorders.

Authors:  Melanie S Harned; Helen R Valenstein
Journal:  F1000Prime Rep       Date:  2013-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.